Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges
Exosomes (versatile, cell-derived nanovesicles naturally endowed with exquisite target-
homing specificity and the ability to surmount in vivo biological barriers) hold substantial …
homing specificity and the ability to surmount in vivo biological barriers) hold substantial …
[HTML][HTML] Progress of exosomes in the diagnosis and treatment of lung cancer
K Xu, C Zhang, T Du, ANA Gabriel, X Wang, X Li… - Biomedicine & …, 2021 - Elsevier
The incidence and mortality of lung cancer account for first place all over the world. Lung
cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in …
cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in …
Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players
Exosomes are nano-vesicles (NVs) secreted by cells and take part in cell-cell
communications. Lately, these exosomes were proved to have dual faces in cancer …
communications. Lately, these exosomes were proved to have dual faces in cancer …
Exosomes as drug carriers for cancer therapy
Exosomes, biological extracellular vesicles, have recently begun to find use in targeted drug
delivery in solid tumor research. Ranging from 30–120 nm in size, exosomes are secreted …
delivery in solid tumor research. Ranging from 30–120 nm in size, exosomes are secreted …
[HTML][HTML] Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes
M Tschuschke, I Kocherova, A Bryja… - Journal of clinical …, 2020 - mdpi.com
Exosomes are a heterogenous subpopulation of extracellular vesicles 30–150 nm in range
and of endosome-derived origin. We explored the exosome formation through different …
and of endosome-derived origin. We explored the exosome formation through different …
Recent advances in nanoparticle-based cancer drug and gene delivery
Effective and safe delivery of anticancer agents is among the major challenges in cancer
therapy. The majority of anticancer agents are toxic to normal cells, have poor bioavailability …
therapy. The majority of anticancer agents are toxic to normal cells, have poor bioavailability …
[HTML][HTML] Trends in research on exosomes in cancer progression and anticancer therapy
D Sinha, S Roy, P Saha, N Chatterjee, A Bishayee - Cancers, 2021 - mdpi.com
Simple Summary Intensive research in the field of cancer biology has discovered a unique
mode of interplay between cells via extracellular bioactive vesicles called exosomes …
mode of interplay between cells via extracellular bioactive vesicles called exosomes …
Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy
Three major approaches of cancer therapy can be enunciated as delivery of biotherapeutics,
tumor image analysis, and immunotherapy. Liposomes, artificial fat bubbles, are long known …
tumor image analysis, and immunotherapy. Liposomes, artificial fat bubbles, are long known …
[HTML][HTML] Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment
A Srivastava, S Rathore, A Munshi… - Seminars in cancer biology, 2022 - Elsevier
Extracellular vesicles (EVs), is the umbrella term used for different types of vesicles
produced by the cells, among which exosomes form the largest group. Exosomes perform …
produced by the cells, among which exosomes form the largest group. Exosomes perform …
Subpopulations of extracellular vesicles and their therapeutic potential
Extracellular vesicles (EVs), such as exosomes and microvesicles, have over the last 10–15
years been recognized to convey key messages in the molecular communication between …
years been recognized to convey key messages in the molecular communication between …